SMITH ASSET MANAGEMENT GROUP LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$2,0000.0%1800.0%0.00%
Q1 2021$2,000
-95.8%
180
-96.7%
0.00%
-100.0%
Q4 2020$48,000
-22.6%
5,3800.0%0.00%0.0%
Q3 2020$62,000
-92.9%
5,380
-95.8%
0.00%
-88.5%
Q4 2015$870,000
+0.3%
129,420
-13.7%
0.03%
-21.2%
Q3 2015$867,000
-29.2%
149,930
-0.0%
0.03%
-19.5%
Q2 2015$1,224,000
+2.1%
149,960
+2.0%
0.04%
+2.5%
Q1 2015$1,199,000
+60.1%
146,969
+80.1%
0.04%
+53.8%
Q4 2014$749,000
-15.4%
81,590
-9.1%
0.03%
-21.2%
Q3 2014$885,000
-9.1%
89,800
-0.3%
0.03%
-8.3%
Q2 2014$974,00090,1100.04%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders